InnAccel} ‘Innovating and Indigenizing MedTech for Indian Healthcare’


This innovative medtech company directly addresses the challenges facing consumers and healthcare systems in India and emerging markets.

The medtech industry in India faces several challenges including lack of skilled manpower, equipment and organization. However, the most pressing challenge is the heavy dependence of Indian healthcare on imported medical equipment.


Read more: {Crypto watch: Cashaa} A single bank account for fiat and crypto for personal and commercial banking


InnAccel Technologies Pvt Ltd. It is creating a portfolio of innovative medical devices designed, engineered and priced for the global market. It uses the Stanford Biodiagnosing Method to identify and validate critical unmet clinical needs in India.

Tech Panda Siraj Dhanani, CEO and Founder of InnAccel Technologies, talks about the challenges MedTech is trying to solve.

Siraj Dhanani

We believe it is time for the Indian medtech ecosystem to come to the fore and take center stage in the global healthcare ecosystem at par with our pharma counterparts.

“India imports more than 80% of medical equipment. Developed in the West, these facilities are suited to their infrastructure with 24*7 electricity, highly trained nurses, OTT staff and compressed gas lines. This resource intensive infrastructure is not available in India and this has limited the adoption of these technologies in India, he explains.

“InnAccel is trying to change that by building first-world technologies, clinically superior to Western technologies, and compatible with the resource constraints and price volatility in India and Indian-like markets,” he added.

What do they do?

InnAccel will use the Biodiversity methodology taught by Stanford University to identify critical unmet needs in India through a three-to-four-month clinical immersion at a partner hospital.

A conceptual solution is designed to address the selected need, using a proprietary product engineering and development platform to create a regulatory proven product. This strategic approach has resulted in several products in two focus areas: critical care and maternal and child care.

At InnAccel we have long believed in inventing and locally manufacturing technologies suited to India’s unique healthcare needs.

Through its proprietary engineering development platform, InnAccel has developed three new patented technologies compatible with India’s healthcare system and capacity constraints, for which it has received national and international certifications and is manufacturing in India.

“We believe it is time for India’s medtech ecosystem to come to prominence and be at par with our pharma counterparts in the global healthcare ecosystem,” says Dhanani.

They focus primarily on two areas of medicine, critical care, maternal and child health, an area that conservatively accounts for at least four million deaths each year.

“We aim to solve these critical problems and save lives by first patenting these gaps in world-controversial technologies,” he added.

Origin and inspiration.

InnAccel started in 2012 as a medtech accelerator with the aim of supporting foreign startups in this space. In the year In 2015, the company began to emphasize creating its own product line for specific needs using the biodesign process.

In the year In 2019, InnAcel integrated operations with its predecessors Coeo Labs and Sattva Medtech, to form an entity with a portfolio of innovative life-saving products in specialty areas.

Our approach is aligned with the Make in India vision, and we seek innovation in India for the world.

“At InnAcel, we have long believed in inventing and indigenously manufacturing technologies suited to India’s unique healthcare needs. Our approach is in line with the Make in India vision and we want to innovate in India for the world,” says Dhanani.

Development history

Already, InnAccel has treated more than 20,000 patients and saved the lives of 6-8,000 children in India.

With the Covid-19 squeeze on healthcare, Danone predicts good things about the impact it could have on medical device sales in consumables and implants.


Read More: {Launch Time: Coreyo} Single Window Logistics Platform and Fully Integrated Mail Aggregation Platform in SaaS Model


“Healthcare and medical technology have been in high demand during the Covid pandemic – their importance in managing the crisis has become clear. This enhanced focus on healthcare and medical technologies will continue in the future and we expect to see increased interest in indigenously developed technologies that are adapted to the Indian ecosystem and can have a significant impact in real-world settings,” he said.



Post Views:
2,384




Source link

Related posts

Leave a Comment

7 − two =